Repligen Corp (NASDAQ:RGEN)

30.81
Delayed Data
As of Mar 30
 +0.24 / +0.79%
Today’s Change
12.31
Today|||52-Week Range
34.15
+55.61%
Year-to-Date

Today’s Trading

Previous close30.57
Today’s open30.81
Day’s range30.44 - 31.25
Volume283,200
Average volume (3 months)386,000
Market cap$1.0B
Dividend yield--
Data as of 3:59pm ET, 03/30/2015

Growth & Valuation

Earnings growth (last year)-50.00%
Earnings growth (this year)+14.00%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-6.78%
P/E ratio125.4
Price/Sales10.13
Price/Book8.97

Competitors

 Today’s
change
Today’s
% change
ZSPHZS Pharma Inc+1.61+3.93%
INSMInsmed Inc+0.59+2.88%
TXMDTherapeuticsMD Inc+0.20+3.33%
ARRYArray Biopharma Inc+0.14+1.89%
Data as of 4:01pm ET, 03/30/2015

Financials

Next reporting dateMay 7, 2015
EPS forecast (this quarter)$0.07
Annual revenue (last year)$63.5M
Annual profit (last year)$8.2M
Net profit margin12.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO, Treasurer, Director &
CAO
Walter C. Herlihy
Chief Operating Officer &
Director
Tony J. Hunt
Corporate headquarters
Waltham, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account